Announcements - DrugBank Blog

Announcements

NIH Discontinues their Drug Interaction API

Discover DrugBank's Drug-Drug Interaction Checker and how we work with NIH.

Announcements

A Year in Review: DrugBank’s 2022 Highlights

We made some big moves in 2022 and we’re so proud of how far we’ve come!

Announcements

What do you get when a compensation plan prioritizes a thriving life?

A Thriving Lifestyle Compensation Philosophy creates more than just a paycheque for our growing team.

Drug Discovery

eBook: The Little Book of Big Changes in AI-Powered Drug Discovery

Read our latest eBook to see all the ways AI is transforming drug discovery and the future of biomedical research.

Announcements

A Year in Review: DrugBank’s 2021 Highlights

The last year allowed for huge growth and achievements in the DrugBank company and we’re proud to share them with you.

Announcements

Introducing the Drug Allergy Module

Our new Drug Allergy Module gives you detailed drug allergy and cross-sensitivities information. You can help your clinical users avoid severe drug allergies and manage mild symptoms with ease.

press releases

DrugBank Announces Successful Fundraise, Plans to Scale Rapidly.

October 5, 2020 - FOR IMMEDIATE RELEASE. The DrugBank team is pleased to announce the completion of a successful investment round. Over the past year, DrugBank has focused its efforts to scale its business, setting ambitious goals for growth, and targeting opportunities to help them accomplish those goals. This included

Announcements

FDA Approvals Monthly Roundup: June 2020

The FDA is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs. Each month, the administration approves numerous new therapeutics. We have summarized the FDA approvals for June below. You can use the hot links to learn more about the drugs. Artesunate

Announcements

A Year in Review: DrugBank's 2019 Highlights

Happy New Year from our team here at DrugBank! 2019 was a wild year for us, and we wanted to share some of our top highlights with you: 1. We added 8 new team members to our growing company! We added roles in sales, operations, administration, curation, development, customer success,

press releases

Edmonton Startup DrugBank accepted into Creative Destruction Lab - West 2019/20 Cohort

Edmonton based startup, DrugBank, has been accepted into the 2019/20 Creative Destruction Lab (CDL) program year. CDL is a seed-stage program for massively scalable, science-based companies. Its nine-month program pairs founders with experienced entrepreneurs and investors to set focused, measurable objectives with the goal of maximizing equity-value creation. Founded

Announcements

DrugBank is Crossing the Pond!

JOIN US AT THE 2019 AI IN DRUG DEVELOPMENT CONGRESS. We are hopping on a red-eye this week headed to London, UK, to take part in the 2019 AI in Drug Development Congress [https://www.oxfordglobal.co.uk/artificialintelligence-congress/]. We’re really excited to be participating in the Congress, and

Announcements

DrugBank wins Prairie High-Growth Startup of the Year Award by Startup Canada

Startup Canada Press Release: DrugBank received the Startup Canada Prairie High-Growth Startup of the Year Award in Edmonton, presented by Mastercard Canada. As a proud sponsor of the sixth annual Startup Canada Awards, we are thrilled to recognize and celebrate outstanding achievement in Canada's entrepreneurship and innovation community

Announcements

DrugBank partners with Ontotext to accelerate Pharma Research

DrugBank is pleased to announce its partnership with OntoText, which will empower commercial and academic Pharma and Healthcare researchers even further in their efforts to discover and repurpose drugs for treating various illnesses.